Human IFN-γ T cell ELISPOT antibody pair - 10-plate

SKU
CT640-10
Validated ELISPOT antibody pair; reagents available separately (960 determinations).
Format
10-plate
Price
€ 655
Documentation
Data sheet
Manual
SDS
Reactivity
Human
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
3458

References

Authors, et al. Title Journal Year Volume Pages
Liangen Chen B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B J Immunol 2007 178 6634-41
Jeroen Stoop Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B Virology 2007 361 141-8
Roberto Mallone CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes Diabetes 2007 56 613-21
Takaichi Hamano A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production J Virol 2007 81 1528-33
M Shi Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro Clin Exp Immunol 2007 147 277-86
Jeroen Gerrits Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches Nephrol Dial Transplant 2007 22 353-61
Adriaan Bins Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients J Immunother 2007 30 234-9
Ming Lv Structured to reduce the mitogenicity of anti-CD3 antibody based on computer-guided molecular design Int J Biochem Cell Biol 2007 39 1142-55
F Kloosterboer Similar potential to become activated and proliferate but differential kinetics and profiles of cytokine production of umbilical cord blood T cells and adult blood naive and memory T cells Hum Immunol 2006 67 874-83
Xing-kui Xue Influence on the immune function of the human peripheral blood mononuclear cells transfected by retrovirus-mediated HSV-tk gene Chin Med J (Engl) 2006 119 1038-41